$GEN #Genmab A/S GENMAB: 2020 guidance reiterated on the back of a strong first quarter | BUY | DKK1900(+12%): GENMAB - BUY | DKK1900(+12%) 2020 guidance reiterated on the back of a strong first quarter Robust financials driven by a… https://t.co/dnRuTIFCbr #equity #stocks https://t.co/ZhQ1BWd69t